254 related articles for article (PubMed ID: 24659533)
1. Quantitative muscle ultrasound versus quantitative magnetic resonance imaging in facioscapulohumeral dystrophy.
Janssen BH; Pillen S; Voet NB; Heerschap A; van Engelen BG; van Alfen N
Muscle Nerve; 2014 Dec; 50(6):968-75. PubMed ID: 24659533
[TBL] [Abstract][Full Text] [Related]
2. Muscle Quantitative MR Imaging and Clustering Analysis in Patients with Facioscapulohumeral Muscular Dystrophy Type 1.
Lareau-Trudel E; Le Troter A; Ghattas B; Pouget J; Attarian S; Bendahan D; Salort-Campana E
PLoS One; 2015; 10(7):e0132717. PubMed ID: 26181385
[TBL] [Abstract][Full Text] [Related]
3. Quantitative muscle MRI and ultrasound for facioscapulohumeral muscular dystrophy: complementary imaging biomarkers.
Mul K; Horlings CGC; Vincenten SCC; Voermans NC; van Engelen BGM; van Alfen N
J Neurol; 2018 Nov; 265(11):2646-2655. PubMed ID: 30191320
[TBL] [Abstract][Full Text] [Related]
4. Three-dimensional quantitative muscle ultrasound in patients with facioscapulohumeral dystrophy and myotonic dystrophy.
de Jong L; Greco A; Nikolaev A; Weijers G; van Engelen BGM; de Korte CL; Fütterer JJ
Muscle Nerve; 2023 Oct; 68(4):432-438. PubMed ID: 37497843
[TBL] [Abstract][Full Text] [Related]
5. Clinical Muscle Testing Compared with Whole-Body Magnetic Resonance Imaging in Facio-scapulo-humeral Muscular Dystrophy.
Regula JU; Jestaedt L; Jende F; Bartsch A; Meinck HM; Weber MA
Clin Neuroradiol; 2016 Dec; 26(4):445-455. PubMed ID: 25860436
[TBL] [Abstract][Full Text] [Related]
6. Muscle MRI of facioscapulohumeral dystrophy (FSHD): A growing demand and a promising approach.
Fatehi F; Salort-Campana E; Le Troter A; Bendahan D; Attarian S
Rev Neurol (Paris); 2016 Oct; 172(10):566-571. PubMed ID: 27663058
[TBL] [Abstract][Full Text] [Related]
7. MRI as outcome measure in facioscapulohumeral muscular dystrophy: 1-year follow-up of 45 patients.
Andersen G; Dahlqvist JR; Vissing CR; Heje K; Thomsen C; Vissing J
J Neurol; 2017 Mar; 264(3):438-447. PubMed ID: 28000006
[TBL] [Abstract][Full Text] [Related]
8. Adding quantitative muscle MRI to the FSHD clinical trial toolbox.
Mul K; Vincenten SCC; Voermans NC; Lemmers RJLF; van der Vliet PJ; van der Maarel SM; Padberg GW; Horlings CGC; van Engelen BGM
Neurology; 2017 Nov; 89(20):2057-2065. PubMed ID: 29030457
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of MRI changes in thigh muscles of patients with Facioscapulohumeral dystrophy: A quantitative study.
Fatehi F; Salort-Campana E; Le Troter A; Lareau-Trudel E; Bydder M; Fouré A; Guye M; Bendahan D; Attarian S
PLoS One; 2017; 12(8):e0183825. PubMed ID: 28841698
[TBL] [Abstract][Full Text] [Related]
10. Leg Muscle Involvement in Facioscapulohumeral Muscular Dystrophy: Comparison between Facioscapulohumeral Muscular Dystrophy Types 1 and 2.
Mair D; Huegens-Penzel M; Kress W; Roth C; Ferbert A
Eur Neurol; 2017; 77(1-2):32-39. PubMed ID: 27855411
[TBL] [Abstract][Full Text] [Related]
11. Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy.
Kan HE; Scheenen TW; Wohlgemuth M; Klomp DW; van Loosbroek-Wagenmans I; Padberg GW; Heerschap A
Neuromuscul Disord; 2009 May; 19(5):357-62. PubMed ID: 19329315
[TBL] [Abstract][Full Text] [Related]
12. Dynamic magnetic resonance imaging of muscle contraction in facioscapulohumeral muscular dystrophy.
Deligianni X; Santini F; Paoletti M; Solazzo F; Bergsland N; Savini G; Faggioli A; Germani G; Monforte M; Ricci E; Tasca G; Pichiecchio A
Sci Rep; 2022 May; 12(1):7250. PubMed ID: 35508609
[TBL] [Abstract][Full Text] [Related]
13. Five-year follow-up study on quantitative muscle magnetic resonance imaging in facioscapulohumeral muscular dystrophy: The link to clinical outcome.
Vincenten SCC; Mul K; van As D; Jansen JJ; Heskamp L; Heerschap A; van Engelen BGM; Voermans NC
J Cachexia Sarcopenia Muscle; 2023 Aug; 14(4):1695-1706. PubMed ID: 37218549
[TBL] [Abstract][Full Text] [Related]
14. Correlation Between Quantitative MRI and Muscle Histopathology in Muscle Biopsies from Healthy Controls and Patients with IBM, FSHD and OPMD.
Lassche S; Küsters B; Heerschap A; Schyns MVP; Ottenheijm CAC; Voermans NC; van Engelen BGM
J Neuromuscul Dis; 2020; 7(4):495-504. PubMed ID: 32925090
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound pattern of anterolateral leg muscles in facioscapulohumeral muscular dystrophy.
Veltsista D; Chroni E
Acta Neurol Scand; 2021 Aug; 144(2):216-220. PubMed ID: 33844852
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound Imaging of Muscle Contraction of the Tibialis Anterior in Patients with Facioscapulohumeral Dystrophy.
Gijsbertse K; Goselink R; Lassche S; Nillesen M; Sprengers A; Verdonschot N; van Alfen N; de Korte C
Ultrasound Med Biol; 2017 Nov; 43(11):2537-2545. PubMed ID: 28764967
[TBL] [Abstract][Full Text] [Related]
17. MRI change metrics of facioscapulohumeral muscular dystrophy: Stir and T1.
Ferguson MR; Poliachik SL; Budech CB; Gove NE; Carter GT; Wang LH; Miller DG; Shaw DWW; Friedman SD
Muscle Nerve; 2018 Jun; 57(6):905-912. PubMed ID: 29236297
[TBL] [Abstract][Full Text] [Related]
18. Distinct disease phases in muscles of facioscapulohumeral dystrophy patients identified by MR detected fat infiltration.
Janssen BH; Voet NB; Nabuurs CI; Kan HE; de Rooy JW; Geurts AC; Padberg GW; van Engelen BG; Heerschap A
PLoS One; 2014; 9(1):e85416. PubMed ID: 24454861
[TBL] [Abstract][Full Text] [Related]
19. Muscle fibrosis as a prognostic biomarker in facioscapulohumeral muscular dystrophy: a retrospective cohort study.
Ragozzino E; Bortolani S; Di Pietro L; Papait A; Parolini O; Monforte M; Tasca G; Ricci E
Acta Neuropathol Commun; 2023 Oct; 11(1):165. PubMed ID: 37849014
[TBL] [Abstract][Full Text] [Related]
20. Muscle MRI findings in facioscapulohumeral muscular dystrophy.
Gerevini S; Scarlato M; Maggi L; Cava M; Caliendo G; Pasanisi B; Falini A; Previtali SC; Morandi L
Eur Radiol; 2016 Mar; 26(3):693-705. PubMed ID: 26115655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]